Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe

Journal of Clinical Microbiology

Volumn 49, Issue 6, 2011, Pages 2325-2327

  Islam, Mohammad S ^a   Mahmud, Zahid H ^a   Ansaruzzaman, Mohammad ^a   Faruque, Shah M ^a   Talukder, Kaisar A ^a   Qadri, Firdausi ^a   Alam, Munirul ^a   Islam, Shafiqul ^a   Bardhan, Pradip K ^a   Mazumder, Ramendra N ^a   Khan, Azharul I ^a   Ahmed, Sirajuddin ^a   Iqbal, Anwarul ^a   Chitsatso, Owen ^b   Mudzori, James ^b   Patel, Sheetal ^c   Midzi, Stanley M ^b   Charimari, Lincoln ^d   Endtz, Hubert P ^a,e   Cravioto, Alejandro ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^c Communicable Disease Control ^*  (Zimbabwe)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHOLERA; GENE AMPLIFICATION; GENOTYPE PHENOTYPE CORRELATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VIBRIO CHOLERAE; ZIMBABWE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHOLERA; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; VIBRIO CHOLERAE; ZIMBABWE;

VIBRIO CHOLERAE;

EID: 79957449755     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00432-11     Document Type: Article

References (16)

1. Ansaruzzaman, M., et al. 2007. Genetic diversity of El Tor strains of Vibrio cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique. Int. J. Med. Microbiol. 297:443-449.
2. Ansaruzzaman, M., et al. 2004. Cholera in Mozambique, variant of Vibrio cholerae. Emerg. Infect. Dis. 10:2057-2059.
3. Bauer, A. W., W. M. M. Kirby, J. C. Sherris, and M. Truck. 1966. Antibiotic susceptibility testing by a standardized single method. Am. J. Clin. Pathol. 45:493-496.
4. Choi, S. Y., et al. 2010. Multilocus variable number tandem repeats analysis (MLVA) of Vibrio cholerae O1 El Tor strains harboring classical toxin B. J. Med. Microbiol. doi:10.1099/jmm.0.017939-0.
5. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests; approved standard, 10th ed. M02-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Glass, R. I., et al. 1983. Plasmid-borne multi-drug resistance in Vibrio cholerae serogroup O1 biotype El Tor: evidence for a point source outbreak in Bangladesh. J. Infect. Dis. 147:204-209.
7. Greenough, W. B., III, R. S. Gordon, Jr., I. S. Rosenberg, B. I. Davies, and A. S. Benenson. 1964. Tetracycline in the treatment of cholera. Lancet i:355-357.
8. Islam, M. S., S. M. Midzi, L. Charimari, A. Carvioto, and H. P. Endtz. 2009. Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrhoeal patients in Zimbabwe. JAMA 302:2321-2322.
9. Lee, J. H., et al. 2006. Multilocus sequence typing (MLST) analysis of Vibrio cholerae O1 El Tor isolates from Mozambique that harbour the classical CTX prophage. J. Med. Microbiol. 55:165-170.
10. Mandomando, I., et al. 2007. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique. J. Antimicrob. Chemother. 60:662-664.
11. Nair, G. B., et al. 2002. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J. Clin. Microbiol. 40:3296-3299.
12. National Committee for Clinical Laboratory Standards. 2001. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline M23-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
13. Nusrin, S., et al. 2004. Diverse CTX phages among toxigenic Vibrio cholerae O1 and O139 strains isolated between 1994 and 2002 in an area where cholera is endemic in Bangladesh. J. Clin. Microbiol. 42:5854-5856.
14. Sack, D. A., R. B. Sack, G. B. Nair, and A. K. Siddique. 2004. Cholera. Lancet 363:223-233.
15. Saha, D., et al. 2006. Single-dose azithromycin for the treatment of cholera in adults. N. Engl. J. Med. 354:2452-2462.
16. World Health Organization. 2008. Global task force on cholera control. Cholera country profile: Zimbabwe. 19 December 2008. World Health Organization, Geneva, Switzerland. http://www.who.int/cholera/countries/ ZimbabweCountryProfile2008.pdf.